<!DOCTYPE html>
<html>
  <head>
    <title>Cardiovascular Disease Risk Assessment</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Roryâ€™s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/cardiovascular/">cardiovascular</a></li>
      <li><a href="/notes/cardiovascular/cardiovasulcar risk management/">cardiovasulcar risk management</a></li>
      <li class="active">Cardiovascular Disease Risk Assessment</li>
  </ol>

  <div class="page-header">
 
    <h1>Cardiovascular Disease Risk Assessment</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Cardiovascular Disease Risk Assessment</strong></a>
          <div class="toc">
<ul>
<li><a href="#recommendations">Recommendations</a></li>
<li><a href="#cardiovascular-disease-risk-assessment">Cardiovascular disease risk assessment</a><ul>
<li><a href="#intervention">Intervention</a></li>
<li><a href="#recommended-age-to-offer-cardiovascular-risk-assessment">Recommended age to offer cardiovascular risk assessment</a></li>
</ul>
</li>
<li><a href="#what-to-measure-and-record-for-cvra">What to measure and record for CVRA</a><ul>
<li><a href="#history">History</a></li>
<li><a href="#family-history">Family History</a></li>
<li><a href="#past-medical-history">Past medical history</a></li>
<li><a href="#measure">Measure</a></li>
<li><a href="#diabetes">Diabetes</a></li>
<li><a href="#atrial-fibrillation-confirmed-on-ecg">Atrial fibrillation - confirmed on ECG</a></li>
</ul>
</li>
<li><a href="#estimating-5yr-cardiovascular-risk-the-charts">Estimating 5yr cardiovascular risk - the charts:</a><ul>
<li><a href="#very-high-risk-groups-6220">Very high risk groups: >20%</a></li>
<li><a href="#people-aged-35-74-yrs">People aged 35-74 yrs</a></li>
<li><a href="#people-aged-35yrs-with-known-risk-factors">People aged \&lt;35yrs with known risk factors</a></li>
<li><a href="#people-aged-6275yo-depending-on-other-risk-factors">People aged >75yo; depending on other risk factors</a></li>
<li><a href="#note-risk-charts-may-underestimate-risk-in">Note: risk charts may underestimate risk in:</a></li>
<li><a href="#follow-up-intervals">Follow-up intervals</a><ul>
<li><a href="#microalbuminuria-definition">Microalbuminuria definition</a></li>
</ul>
</li>
</ul>
</li>
<li><a href="#cardiovascular-risk-factor-management-goals">Cardiovascular risk factor management goals</a><ul>
<li><a href="#aim-of-treatment-is-to-reduce-cvd-risk">Aim of treatment is to reduce CVD risk</a></li>
<li><a href="#management-guidance">Management guidance:</a></li>
</ul>
</li>
<li><a href="#medication-management">Medication Management</a><ul>
<li><a href="#blood-pressure-lowering">Blood pressure lowering</a><ul>
<li><a href="#between-10-20">Between 10-20%</a></li>
<li><a href="#6220">>20%</a></li>
</ul>
</li>
</ul>
</li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <blockquote>
<p>Update 2013: NZ Primary Care Handbook 2012</p>
<ul>
<li>
<p>New CVDRA equation available 2014</p>
</li>
<li>
<p>Management options discussed with all patients</p>
</li>
<li>
<p>Increasingly graded approach to the intensity of management</p>
</li>
<li>
<p>Combined risk replaces absolute risk</p>
</li>
<li>
<p><strong>Overarching principle</strong> is that intensity of interventions proportional to size of estimated cvd risk.</p>
</li>
</ul>
</blockquote>
<p><a href="http://www.knowyournumbers.co.nz/heart-age-forecast.aspx">your heart forecast</a></p>
<h3 id="recommendations">Recommendations</h3>
<ul>
<li>
<p>All patients benefit from healthier lifestyles</p>
</li>
<li>
<p>Most patients with 5yr combined risk \&lt;10% well managed without drug treatment</p>
</li>
<li>
<p>5yr CVD risk 10-20%</p>
</li>
<li>
<p>discussion about benefits and harms of BP lowering and lipid lowering drugs</p>
</li>
<li>
<p>shared decision to initiate:</p>
<ul>
<li>
<p>lifestyle only</p>
</li>
<li>
<p>add BP dec.</p>
</li>
<li>
<p>add lipid lowering</p>
</li>
<li>
<p>ALL</p>
</li>
</ul>
</li>
<li>
<p>Most patients with CVD risk >20% benefit significantly from <em>both</em> BP and lipid lowering and antiplatelet drugs + <strong>intensive non-pharmacological interventions</strong> </p>
</li>
<li>
<p>Patients at any age with significant individual risk factors need to have them managed</p>
</li>
</ul>
<h3 id="cardiovascular-disease-risk-assessment">Cardiovascular disease risk assessment</h3>
<ul>
<li>
<p>Shared treatment decisions form basis of managing cardiovascular risk</p>
</li>
<li>
<p>Take into account: </p>
<ul>
<li>
<p>individuals estimated 5yr combined CVD risk</p>
</li>
<li>
<p>magnitude of absolute benefits</p>
</li>
<li>
<p>harms of intervention</p>
</li>
</ul>
</li>
</ul>
<h4 id="intervention">Intervention</h4>
<ul>
<li>
<p>Lifestyle</p>
<ul>
<li>
<p>diet </p>
</li>
<li>
<p>exercise</p>
</li>
<li>
<p>smoking</p>
</li>
</ul>
</li>
<li>
<p>lipid lowering</p>
</li>
<li>
<p>blood pressure lowering</p>
</li>
<li>
<p>antiplatelet medication</p>
</li>
<li>
<p>diabetes care</p>
</li>
<li>
<p>medication after:</p>
<ul>
<li>
<p>myocardial infarction</p>
</li>
<li>
<p>stroke</p>
</li>
<li>
<p>other cardiovascular events</p>
</li>
</ul>
</li>
</ul>
<h4 id="recommended-age-to-offer-cardiovascular-risk-assessment">Recommended age to offer cardiovascular risk assessment</h4>
<ul>
<li>
<p><strong>Men 45/women 55</strong></p>
<ul>
<li>Asymptomatic without known risk factors:</li>
</ul>
</li>
<li>
<p><strong>Men 35yo/women 45yo</strong></p>
<ul>
<li>
<p>Maori/pacific/indo-asian:</p>
</li>
<li>
<p>with other known risk factors or high risk of developing diabetes</p>
<ul>
<li>
<p>Family history risk factors:</p>
<ul>
<li>
<p>Diabetes in 1st-degree relative </p>
</li>
<li>
<p>Premature CAD or ischaemic stroke in a first-degree relative (male \&lt;55yrs, female \&lt;65yrs)</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Personal history risk factors</p>
<ul>
<li>
<p>People who smoke (or who have quit in last 12 months)</p>
</li>
<li>
<p>Gestational diabetes, PCOS</p>
</li>
<li>
<p>Prior hypertension (BP >160/90)</p>
</li>
<li>
<p>Prior TC:HDL ratio >= 7</p>
</li>
<li>
<p>BMI >30 or truncal obesity: >100cm men, >90cm women</p>
</li>
<li>
<p>eGFR \&lt;60</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p><strong>Annually from time of diagnosis</strong></p>
<ul>
<li>
<p>DM</p>
<ul>
<li>
<p>type 1 </p>
</li>
<li>
<p>type 2</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>It is reasonable to not see face-face if things have not significantly changed</p>
</li>
<li>
<p>if CVRA \&lt;5% review/reassess within the next <strong>10 years</strong></p>
</li>
</ul>
<h3 id="what-to-measure-and-record-for-cvra">What to measure and record for CVRA</h3>
<h4 id="history">History</h4>
<ul>
<li>
<p>Age</p>
</li>
<li>
<p>Gender</p>
</li>
<li>
<p>Ethnicity</p>
</li>
<li>
<p>Smoking status (if stopped \&lt;12/12 record as smoker)</p>
</li>
</ul>
<h4 id="family-history">Family History</h4>
<ul>
<li>
<p>Premature coronary heart disease/ischaemic stroke first deg. rel</p>
<ul>
<li>
<p>male \&lt;55yo</p>
</li>
<li>
<p>female \&lt;65</p>
</li>
</ul>
</li>
<li>
<p>Type 2 DM</p>
</li>
<li>
<p>Genetic lipid disorder</p>
</li>
</ul>
<h4 id="past-medical-history">Past medical history</h4>
<ul>
<li>
<p>Past history of cardiovascular disease</p>
<ul>
<li>
<p>MI</p>
</li>
<li>
<p>PCI</p>
</li>
<li>
<p>CABG</p>
</li>
<li>
<p>Angina</p>
</li>
<li>
<p>Ischaemic stroke</p>
</li>
<li>
<p>TIA</p>
</li>
<li>
<p>peripheral vascular disease</p>
</li>
</ul>
</li>
<li>
<p>Genetic lipid disorder</p>
<ul>
<li>
<p>familial hypercholesterolaemia</p>
</li>
<li>
<p>Familial defective ApoB</p>
</li>
<li>
<p>Familial combined dyslipidaemia</p>
</li>
</ul>
</li>
</ul>
<h4 id="measure">Measure</h4>
<ul>
<li>
<p>Lipids</p>
<ul>
<li>
<p>single <strong>non-fasting</strong> TC:HDL ratio used in calculation</p>
</li>
<li>
<p>If TC or TC:HDL >8mmol/l repeat the test</p>
<ul>
<li>There is a possibility of genetic lipid disorder if TC>8 and/or strong FHx of premature CAD</li>
</ul>
</li>
</ul>
</li>
<li>
<p>HBA1c</p>
<ul>
<li>Use single non-fasting HbA1c to screen for diabetes at same time as lipid profile</li>
</ul>
</li>
<li>
<p>Blood pressure</p>
<ul>
<li>
<p>Sitting BP measurement</p>
</li>
<li>
<p>2 seated BP measurements recommended for initial risk assessment</p>
<ul>
<li>one each arm</li>
</ul>
</li>
<li>
<p>use appropriate cuff</p>
<ul>
<li>
<p>Small adult (22-26cm = 24cm)</p>
</li>
<li>
<p>Adult (27-34cm = 30cm)</p>
</li>
<li>
<p>Large adult 35-44cm (38)</p>
</li>
<li>
<p>Adult thigh (45-52)</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>BMI</p>
<ul>
<li>
<p>Doesnâ€™t:</p>
<ul>
<li>
<p>distinguish between fat and lean mass</p>
</li>
<li>
<p>ethnic differences</p>
</li>
<li>
<p>measure actual body fat or provide information about distribution of body fat</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Waist circumference</p>
<ul>
<li>midway between lower rib margin and iliac crest to nearest 1cm</li>
</ul>
</li>
</ul>
<h4 id="diabetes">Diabetes</h4>
<ul>
<li>
<p>Date of diagnosis</p>
</li>
<li>
<p>Type of diabetes</p>
</li>
<li>
<p>HBA1c</p>
</li>
<li>
<p>Urine albumin: creatinine (ACR)</p>
</li>
<li>
<p>eGFR and history of renal disease</p>
</li>
</ul>
<h4 id="atrial-fibrillation-confirmed-on-ecg">Atrial fibrillation - confirmed on ECG</h4>
<ul>
<li>
<p>Echocardiogram</p>
</li>
<li>
<p>Past history of:</p>
<ul>
<li>
<p>stroke</p>
</li>
<li>
<p>TIA  </p>
<p>heart failure</p>
</li>
<li>
<p>rheumatic or mitral heart disease</p>
</li>
</ul>
</li>
</ul>
<h3 id="estimating-5yr-cardiovascular-risk-the-charts">Estimating 5yr cardiovascular risk - the charts:</h3>
<h4 id="very-high-risk-groups-6220">Very high risk groups: >20%</h4>
<ul>
<li>
<p>Previous CVD event</p>
</li>
<li>
<p>Some genetic lipid disorders (see above)</p>
</li>
<li>
<p>Diabetes with overt nephropathy</p>
<ul>
<li>
<p>ACR 30mg/mmol</p>
</li>
<li>
<p>urinary albumin 200mg/L</p>
</li>
</ul>
</li>
<li>
<p>Diabetes with other renal disease causing renal impairment</p>
<ul>
<li>eGFR \&lt;60</li>
</ul>
</li>
</ul>
<h4 id="people-aged-35-74-yrs">People aged 35-74 yrs</h4>
<ul>
<li>
<p>Calculate 5yr risk</p>
</li>
<li>
<p>AF confers additional risk over and above</p>
</li>
<li>
<p>These groups moved up one risk group cateogry (5%):</p>
<ul>
<li>
<p>FHx of premature CAD or ischaemic stroke in 1st deg. relative (M \&lt;55yo, F \&lt;65)</p>
</li>
<li>
<p>Maori, pacific people or indo-asian peoples</p>
</li>
<li>
<p>Diabetes with microalbuminuria, persistent proteinuria, <strong>or</strong> DM for 10yrs, <strong>or</strong> HbA1c consistently >64mmol/L</p>
</li>
</ul>
</li>
</ul>
<h4 id="people-aged-35yrs-with-known-risk-factors">People aged \&lt;35yrs with known risk factors</h4>
<ul>
<li>
<p>All calculations outside age ranges of Framingham equation are approximate but can be useful</p>
</li>
<li>
<p>Age \&lt;35:</p>
<ul>
<li>
<p>calculate risk as if 35yrs old</p>
</li>
<li>
<p>Low HDL\&lt;0.7mmol/L - because of risk of genetic lipid disorder</p>
</li>
<li>
<p>Known familial dyslipidaemias or suspected genetic lipid disorders</p>
</li>
<li>
<p>Type 1 DM, Type 2 DM with microalbuminauria, Type 2 DM of long duration (10yrs)</p>
</li>
</ul>
</li>
</ul>
<h4 id="people-aged-6275yo-depending-on-other-risk-factors">People aged >75yo; depending on other risk factors</h4>
<ul>
<li>
<p>calculate risk as if were 65-74yo</p>
</li>
<li>
<p>evidence for lipid lowering in the elderly limited as primary prevention</p>
</li>
<li>
<p>harms vs benefit analysis/discussion more difficult</p>
</li>
<li>
<p>Older people gain similar relative benefit from cholesterol lowering</p>
<ul>
<li>
<p>but are more likely to have <strong>absolute</strong> benefit</p>
</li>
<li>
<p>much higher pre-treatment of cardiovascular risk</p>
</li>
</ul>
</li>
<li>
<p>Cormorbidity is more common</p>
</li>
<li>
<p>time available to derive benefit will be shorter</p>
</li>
<li>
<p>patients' expectations should be taken into account</p>
</li>
</ul>
<h4 id="note-risk-charts-may-underestimate-risk-in">Note: risk charts may underestimate risk in:</h4>
<ul>
<li>
<p>single risk factors:</p>
<ul>
<li>
<p>TC >= 8mmol/L</p>
</li>
<li>
<p>TC:HDL ratio >= 8</p>
</li>
<li>
<p>BP consistently above 170/100 mmHg</p>
</li>
</ul>
</li>
<li>
<p>risk may be higher than assumed 5yr CVD risk of â‰¥15%</p>
</li>
</ul>
<h4 id="follow-up-intervals">Follow-up intervals</h4>
<ul>
<li>
<p>\&lt;5%</p>
<ul>
<li>10yrs</li>
</ul>
</li>
<li>
<p>2013: </p>
<ul>
<li>all others: As soon as practicle</li>
</ul>
</li>
<li>
<p>5-10%</p>
<ul>
<li>5yrs</li>
</ul>
</li>
<li>
<p>10-15%</p>
<ul>
<li>2 years</li>
</ul>
</li>
<li>
<p>â‰¥ 15%, DM or on lipid/BP lowering</p>
<ul>
<li>annual</li>
</ul>
</li>
<li>
<p>DM/medications/smoking cessation treatment/intensive lifestyle advice</p>
<ul>
<li>3mo until controlled then 6mo</li>
</ul>
</li>
</ul>
<h6 id="microalbuminuria-definition">Microalbuminuria definition</h6>
<blockquote>
<p>excretion between 30mg and 300mg of albumin a day in the urine.  </p>
<p>less than 30mg is insignificant.  </p>
<p>more than 300mg is albuminauria or macroalbuminuria.  </p>
</blockquote>
<h3 id="cardiovascular-risk-factor-management-goals">Cardiovascular risk factor management goals</h3>
<ul>
<li>
<p>All treatment decisions should be informed by an individual's estimated 5 year combined CVD risk</p>
</li>
<li>
<p>discussion of magnitude of benefits and type and likelihood of potential harms</p>
</li>
<li>
<p>People will have their own risk thresholds</p>
</li>
</ul>
<h4 id="aim-of-treatment-is-to-reduce-cvd-risk">Aim of treatment is to reduce CVD risk</h4>
<ul>
<li>
<p>The order in which to start interventions should take into account :</p>
</li>
<li>
<p>individual risk factor levels</p>
<ul>
<li>it is easier to modify risk that is very abN than one that is moderatley abN</li>
</ul>
</li>
<li>
<p>potential sie effects</p>
</li>
<li>
<p>other concurrent illness</p>
</li>
<li>
<p>compliance</p>
</li>
<li>
<p>personal preference</p>
</li>
<li>
<p>Blood pressure lowering and statin medications work independently to lower risk</p>
</li>
<li>
<p>Either or both will be effective depending on the combined clinical risk</p>
</li>
<li>
<p><a href="">"Your heart forecast"</a>(http://www.heartfoundation.org.nz)</p>
</li>
</ul>
<h4 id="management-guidance">Management guidance:</h4>
<ul>
<li>
<p>\&lt;10%</p>
<ul>
<li>
<p>lifestyle advice</p>
</li>
<li>
<p>evidence of benefit from antiHTN and statin unclear</p>
</li>
<li>
<p>offer CVD risk 5-10yrs</p>
</li>
</ul>
</li>
<li>
<p>10-20%</p>
<ul>
<li>
<p>specific individualised lifestyle advice</p>
<ul>
<li>
<p>diet</p>
</li>
<li>
<p>physical activity</p>
</li>
<li>
<p>smoking cessation</p>
</li>
</ul>
</li>
<li>
<p>medications</p>
<ul>
<li>
<p>good evidecne demonstrating benefti in this group</p>
</li>
<li>
<p>absolute beneftis smaller at lower levels of combined risk</p>
<ul>
<li>increasing benefit for those with higher</li>
</ul>
</li>
<li>
<p>shared decision making</p>
</li>
</ul>
</li>
<li>
<p>follow-up</p>
<ul>
<li>
<p>as clinically indicated</p>
<ul>
<li>more intensive focus for higher combined risk patients</li>
</ul>
</li>
<li>
<p>if not on drug treatment</p>
<ul>
<li>
<p>1yr 15-20%</p>
</li>
<li>
<p>2yr 10-15%</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>>20%</p>
<ul>
<li>
<p>intensive lifestyle</p>
</li>
<li>
<p>strong evidence for:</p>
<ul>
<li>
<p>BP-lowering</p>
</li>
<li>
<p>statins</p>
</li>
<li>
<p>antiplatelet therapy</p>
</li>
</ul>
</li>
<li>
<p>review annually or as clinically indicated</p>
</li>
</ul>
</li>
<li>
<p>with established CVD</p>
<ul>
<li>initially monitor @ 3mo then as clinically indicated</li>
</ul>
</li>
</ul>
<h2 id="medication-management">Medication Management</h2>
<h3 id="blood-pressure-lowering">Blood pressure lowering</h3>
<ul>
<li>
<p>BP> 170/100 BP lowering treatment usually recommended irrespective of the combined CVD risk</p>
</li>
<li>
<p>\&lt;170/100 informed by combined cardiovascular risk</p>
</li>
</ul>
<h4 id="between-10-20">Between 10-20%</h4>
<ul>
<li>
<p>discuss benefits and risks</p>
</li>
<li>
<p>lifestyle modification</p>
</li>
<li>
<p>aim is to achieve moderate blood pressure reduction to reduce combined risk -> <strong>no target</strong></p>
</li>
</ul>
<h4 id="6220">>20%</h4>
<ul>
<li>
<p>strongly recommended</p>
</li>
<li>
<p>caution if BP \&lt;130/80</p>
</li>
</ul>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
